Superworth

Teladoc Health price to free cash flow TDOC

Market value divided by free cash flow over the last twelve months, since 2020.

Today, Nov 2, 2026
6.0×
7-year median
9.7×
Against its 7-year history
43rd
percentile: 0 is its lowest day, 100 its highest
7-year range
2.9× to 498×
Peer median
16.3×

Teladoc Health's price to free cash flow is 6.0× as of Nov 2, 2026.

That is below its 7-year median of 9.7×, close to the middle of its last 7 years.

Over that time it ranged from 2.9× in Feb 2026 to 498× in May 2020.

The median for 10 hospital and care facility stocks of a similar size is 16.3×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far6.0×2.9×6.1×
20254.5×4.1×7.4×
20244.9×3.8×13.2×
202313.3×9.6×26.3×
202219.8×17.8×63.8×
2021422×422×434×
2020381×267×498×

Against its peers

Companies in Medical - Care Facilities nearest Teladoc Health's size, closest first, today.

CompanyPrice to free cash flow
TDOCTeladoc Health6.0×
ARDTArdent Health5.4×
HCSGHealthcare Services16.3×
PNTGPennant40.8×
USPHU S Physical Therapy19.8×
PGNYProgyny12.6×
OMDAOmada Health48.1×
ADUSAddus HomeCare15.2×
MDPediatrix Medical11.4×
PRVAPrivia Healthn/m
AVAHAveanna Healthcare18.1×
Peer median16.3×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Teladoc Health

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.